Skip to content
EB girl visiting an EB ambulance with his mother.

To overcome clinical trials challenges 

Clinical trials and patient access

EB patients willing and able to participate in clinical trials are essential in the process of developing approved treatments, products and diagnostics. 

Life with EB is difficult, and planning for clinical trials needs to take this into account. It is important to integrate patients in the planning of clinical trials, and companies planning trials are encouraged to contact patient organisations early in the process to ensure this happens.

Challenges for EB patients taking part at clinical trials

  • Timeframe
  • Competing ongoing trials
  • Exclusion criteria
  • Travel & cost
  • Additional clinical tests
  • Family commitments/bereavement
  • Misconception about cell and gene therapies

Recommendations for overcoming some of these challenges:

  • Include patients in the clinical trials design from the start
  • Carefully consider flexibility of eligibility criteria and ensure it is justified
  • Try and open some ‘shared care’ sites such as GP practices or hospitals or meet patients at their home
  • Help patients to book travel and hotels where possible and pay upfront from a study account
  • Have early, late or weekend appointments available where possible to fit around patients' schedules.

Share knowledge about patients needs & perspectives

Owing to legislation, EB-ResNet cannot provide companies with direct access to patient registers, or contact details of individual patients. However, for companies planning clinical trials, opportunities to participate in trials can be communicated to the patient community via EB-ResNet. EB-ResNet does not provide endorsement of specific treatments, trials or products. Patient recruitment to clinical trials can be facilitated through clinical-network partners. EB-ResNet can help companies understand patient perspectives.

Back to main navigation
This website uses cookies to give you the best possible service. By using this website, you agree to the use of cookies. Detailed information can be found in our privacy policy .